This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.

HB1424: (New Title) allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

Bill details

Version history, amendments, and roll-call votes were not present in the imported local bill data.

Sponsors

Topics

No Committee Assignment

Official links

HB 1424 - AS AMENDED BY THE HOUSE

11Mar2020... 0630h

2020 SESSION

20-2298

01/04

HOUSE BILL 1424

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.


AMENDED ANALYSIS

This bill allows alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

11Mar2020... 0630h 20-2298

01/04

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty

AN ACT allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 New Paragraph; Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers; Requirements. Amend RSA 126-X:8 by inserting after paragraph XVIII the following new paragraph:

XIX. An alternative treatment center may acquire, and may use in the manufacture of cannabis concentrate and cannabis infused products, hemp-derived cannabidiol, or CBD, isolate that is not produced by an alterative treatment center in New Hampshire. All such CBD isolate, and all cannabis concentrate and cannabis infused products manufactured from such CBD isolate, shall be tested for contaminants and cannabinoid profile in accordance with this chapter and department rules.

2 Effective Date. This act shall take effect 60 days after its passage.